- Home
- RVPH vs INDO Comparison
RVPH vs INDO Comparison
Compare RVPH & INDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- INDO
- Stock Information
- Founded
- RVPH 2006
- INDO 2018
- Country
- RVPH United States
- INDO Indonesia
- Employees
- RVPH N/A
- INDO N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- INDO Oil & Gas Production
- Sector
- RVPH Health Care
- INDO Energy
- Exchange
- RVPH Nasdaq
- INDO Nasdaq
- Market Cap
- RVPH 32.8M
- INDO 35.1M
- IPO Year
- RVPH N/A
- INDO 2019
- Fundamental
- Price
- RVPH $0.37
- INDO $3.11
- Analyst Decision
- RVPH Strong Buy
- INDO
- Analyst Count
- RVPH 5
- INDO 0
- Target Price
- RVPH $9.00
- INDO N/A
- AVG Volume (30 Days)
- RVPH 2.6M
- INDO 8.5M
- Earning Date
- RVPH 08-13-2025
- INDO 07-15-2025
- Dividend Yield
- RVPH N/A
- INDO N/A
- EPS Growth
- RVPH N/A
- INDO N/A
- EPS
- RVPH N/A
- INDO N/A
- Revenue
- RVPH N/A
- INDO $2,667,508.00
- Revenue This Year
- RVPH N/A
- INDO N/A
- Revenue Next Year
- RVPH N/A
- INDO N/A
- P/E Ratio
- RVPH N/A
- INDO N/A
- Revenue Growth
- RVPH N/A
- INDO N/A
- 52 Week Low
- RVPH $0.30
- INDO $2.06
- 52 Week High
- RVPH $4.28
- INDO $7.95
- Technical
- Relative Strength Index (RSI)
- RVPH 30.28
- INDO 47.97
- Support Level
- RVPH $0.35
- INDO $2.92
- Resistance Level
- RVPH $0.83
- INDO $3.30
- Average True Range (ATR)
- RVPH 0.07
- INDO 0.84
- MACD
- RVPH -0.04
- INDO -0.16
- Stochastic Oscillator
- RVPH 11.32
- INDO 4.77
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About INDO Indonesia Energy Corporation Limited
Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. The company is an independent energy company engaged in the oil and gas business and holds two oil and gas assets through its subsidiaries in Indonesia: The Kruh Block and the Citarum Block. It has also identified a potential third exploration block known as the Rangkas area. . Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.